» Articles » PMID: 24787137

R-loops Associated with Triplet Repeat Expansions Promote Gene Silencing in Friedreich Ataxia and Fragile X Syndrome

Overview
Journal PLoS Genet
Specialty Genetics
Date 2014 May 3
PMID 24787137
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

Friedreich ataxia (FRDA) and Fragile X syndrome (FXS) are among 40 diseases associated with expansion of repeated sequences (TREDs). Although their molecular pathology is not well understood, formation of repressive chromatin and unusual DNA structures over repeat regions were proposed to play a role. Our study now shows that RNA/DNA hybrids (R-loops) form in patient cells on expanded repeats of endogenous FXN and FMR1 genes, associated with FRDA and FXS. These transcription-dependent R-loops are stable, co-localise with repressive H3K9me2 chromatin mark and impede RNA Polymerase II transcription in patient cells. We investigated the interplay between repressive chromatin marks and R-loops on the FXN gene. We show that decrease in repressive H3K9me2 chromatin mark has no effect on R-loop levels. Importantly, increasing R-loop levels by treatment with DNA topoisomerase inhibitor camptothecin leads to up-regulation of repressive chromatin marks, resulting in FXN transcriptional silencing. This provides a direct molecular link between R-loops and the pathology of TREDs, suggesting that R-loops act as an initial trigger to promote FXN and FMR1 silencing. Thus R-loops represent a common feature of nucleotide expansion disorders and provide a new target for therapeutic interventions.

Citing Articles

Recent Advances in the Genetics of Ataxias: An Update on Novel Autosomal Dominant Repeat Expansions.

Pellerin D, Iruzubieta P, Xu I, Danzi M, Cortese A, Synofzik M Curr Neurol Neurosci Rep. 2025; 25(1):16.

PMID: 39820740 DOI: 10.1007/s11910-024-01400-8.


Friedreich Ataxia: An (Almost) 30-Year History After Gene Discovery.

Pandolfo M Neurol Genet. 2025; 11(1):e200236.

PMID: 39810753 PMC: 11731367. DOI: 10.1212/NXG.0000000000200236.


The GAA repeat expansion is a major cause of ataxia in the Cypriot population.

Livanos I, Votsi C, Michailidou K, Pellerin D, Brais B, Zuchner S Brain Commun. 2025; 7(1):fcae479.

PMID: 39801711 PMC: 11724429. DOI: 10.1093/braincomms/fcae479.


Beyond the Synapse: and FMRP Molecular Mechanisms in the Nucleus.

Hansen N, Dischler A, Dias C Int J Mol Sci. 2025; 26(1.

PMID: 39796070 PMC: 11720320. DOI: 10.3390/ijms26010214.


Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease.

Hisey J, Masnovo C, Mirkin S NAR Mol Med. 2024; 1(4):ugae024.

PMID: 39723156 PMC: 11667243. DOI: 10.1093/narmme/ugae024.


References
1.
Herman D, Jenssen K, Burnett R, Soragni E, Perlman S, Gottesfeld J . Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006; 2(10):551-8. DOI: 10.1038/nchembio815. View

2.
Kim E, Napierala M, Dent S . Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia. Nucleic Acids Res. 2011; 39(19):8366-77. PMC: 3201871. DOI: 10.1093/nar/gkr542. View

3.
Marmolino D . Friedreich's ataxia: past, present and future. Brain Res Rev. 2011; 67(1-2):311-30. DOI: 10.1016/j.brainresrev.2011.04.001. View

4.
Castel A, Cleary J, Pearson C . Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol. 2010; 11(3):165-70. DOI: 10.1038/nrm2854. View

5.
Colak D, Zaninovic N, Cohen M, Rosenwaks Z, Yang W, Gerhardt J . Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science. 2014; 343(6174):1002-5. PMC: 4357282. DOI: 10.1126/science.1245831. View